<< Read Full Article
<< Read Full Article
Updated from 11:36 a.m. EST
The board of medical-device company Guidant (GDT Quote) is reportedly meeting Wednesday afternoon to determine which of the firm's two pursuers would make the best merger partner.
Guidant's board has to decide whether to stick with the plan to be acquired by New Jersey's Johnson & Johnson (JNJ Quote) for $21.4 billion, or to go with a higher offer, worth $25 billion, from Boston Scientific (BSX Quote).
Cable television network CNBC reported that the meeting was taking place, and that it started around 3 p.m. EST. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,344.84 | 1,095.63 | 2,144.60 | 32.01 |
Oil *
78.55
|
|
UP
34.92
|
UP
4.14
|
UP
6.16
|
DOWN
0.30
|
10 Yr
3.20%
SPDR Gold
115.65
|
|
+0.34%
|
+0.38%
|
+0.29%
|
-0.93%
|
Data delayed 20 minutes |
Connect with TheStreet